Back
Fossil Group, Inc. Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Buy
62
FOSL
Fossil Group, Inc.
Last Price:
$3.76
Seasonality Move:
5.3%
Sell
39
ZBIO
Zenas BioPharma, Inc.
Last Price:
$36.25
Seasonality Move:
-1.59%
Buy
62
Fossil Group, Inc. (FOSL)
is a Buy
Is Fossil Group, Inc. a Buy, Sell or Hold?
-
The current Fossil Group, Inc. [FOSL] share price is $3.76. The Score for FOSL is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
FOSL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Zenas BioPharma, Inc. (ZBIO)
is a Sell
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $36.31. The Score for ZBIO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
ZBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FOSL Stock Price Chart
What is Fossil Group, Inc.'s stock price today?
-
The Fossil Group, Inc. share price today is $3.76The current trend is moderately bullish and FOSL is experiencing slight selling pressure.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $36.31The current trend is moderately bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
FOSL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.26 | Buy |
| Relative Strength Index (14 RSI): | 59.11 | Buy |
| Chaikin Money Flow: | -149755 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.22 - 3.94) | Buy |
| Bollinger Bands (100): | (2.19 - 3.45) | Buy |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.68 | Buy |
| Relative Strength Index (14 RSI): | 47.21 | Sell |
| Chaikin Money Flow: | 289999 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.8 - 41.14) | Sell |
| Bollinger Bands (100): | (19.01 - 36.29) | Buy |
FOSL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.75 | Buy |
| 20-day SMA: | 3.74 | Buy |
| 50-day SMA: | 2.85 | Buy |
| 200-day SMA: | 2.1 | Buy |
| 8-day EMA: | 3.77 | Sell |
| 20-day EMA: | 3.58 | Buy |
| 50-day EMA: | 3.15 | Buy |
| 200-day EMA: | 2.36 | Buy |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.86 | Sell |
| 20-day SMA: | 38.54 | Sell |
| 50-day SMA: | 35.24 | Buy |
| 200-day SMA: | 19.17 | Buy |
| 8-day EMA: | 35.64 | Buy |
| 20-day EMA: | 24.68 | Buy |
| 50-day EMA: | 12.87 | Buy |
| 200-day EMA: | 3.71 | Buy |
Fossil Group, Inc. Earnings Growth & FOSL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.54 per share, and an increase next year of $0.55 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and an increase next year of $0.15 per share.
Fossil Group, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||